First-line serplulimab plus chemotherapy versus chemotherapy alone in small-cell lung cancer patients with brain metastases: a multicenter, prospective cohort study - Poll - MDSpire

First-line serplulimab plus chemotherapy versus chemotherapy alone in small-cell lung cancer patients with brain metastases: a multicenter, prospective cohort study

  • By

  • Wan Zhang

  • Xiaojun Yang

  • Hualin Chen

  • Xingxiang Pu

  • Reyihanguli Tuohetashi

  • Xuan Wu

  • Zhanhong Xie

  • Di Wu

  • Yongguang Cai

  • Shi Jin

  • Xuli Guo

  • Kaitao Yao

  • Yongfeng Chen

  • Guanming Jiang

  • June 8, 2026

  • 0 min

Share

Original Source(s)

First-line serplulimab plus chemotherapy versus chemotherapy alone in small-cell lung cancer patients with brain metastases: a multicenter, prospective cohort study

  • by Wan Zhang, Xiaojun Yang, Hualin Chen, Xingxiang Pu, Reyihanguli Tuohetashi, Xuan Wu, Zhanhong Xie, Di Wu, Yongguang Cai, Shi Jin, Xuli Guo, Kaitao Yao, Yongfeng Chen, Guanming Jiang

  • June 8, 2026

Related Content

Secondary spontaneous pneumothorax as an initial manifestation of lung cancer: a case report

An exploratory integrative analysis of plasma transcriptomic and proteomic predictors of response to total neoadjuvant therapy in locally advanced rectal cancer

Case report: A challenging case of stage IVB mixed neuroendocrine-non-neuroendocrine neoplasm of the gallbladder treated with extended radical resection including portal vein reconstruction